Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

KROS Q4 2019 Earnings — Keros Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

KROSKeros Therapeutics, Inc.

$424M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

-$2M-65.2% margin

Operating Income

-$3M-109.1% margin

Net Income

-$3M-110.0% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$6M

Stock-Based Comp.

$18,000

Balance Sheet

Total Assets

$11M

Total Liabilities

$10M

Stockholders' Equity

$495,000

Cash & Equivalents

$7M

← FY 2019 All Quarters Q1 2020 →